US6339066B1
(en)
|
1990-01-11 |
2002-01-15 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C
|
US6537973B1
(en)
|
1992-03-16 |
2003-03-25 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide inhibition of protein kinase C
|
US5985558A
(en)
*
|
1997-04-14 |
1999-11-16 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos
|
US6312894B1
(en)
|
1995-04-03 |
2001-11-06 |
Epoch Pharmaceuticals, Inc. |
Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
|
US5801155A
(en)
*
|
1995-04-03 |
1998-09-01 |
Epoch Pharmaceuticals, Inc. |
Covalently linked oligonucleotide minor grove binder conjugates
|
AU734715B2
(en)
|
1996-02-26 |
2001-06-21 |
California Institute Of Technology |
Improved polyamides for binding in the minor groove of double stranded DNA
|
US6555692B1
(en)
|
1996-02-26 |
2003-04-29 |
California Institute Of Technology |
Preparation and use of bifunctional molecules having DNA sequence binding specificity
|
US6506906B1
(en)
|
1996-02-26 |
2003-01-14 |
California Institute Of Technology |
Preparation and use of bifunctional molecules having DNA sequence binding specificity
|
US6090947A
(en)
|
1996-02-26 |
2000-07-18 |
California Institute Of Technology |
Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
|
WO1998045284A1
(en)
|
1996-02-26 |
1998-10-15 |
California Institute Of Technology |
Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
|
US6635417B1
(en)
*
|
1996-07-31 |
2003-10-21 |
California Institute Of Technology |
Complex formation between DSDNA and oligomer of cyclic heterocycles
|
US6143901A
(en)
*
|
1996-07-31 |
2000-11-07 |
Genesoft, Inc. |
Complex formation between dsDNA and pyrrole imidazole polyamides
|
CN1260006A
(zh)
|
1996-02-26 |
2000-07-12 |
加利福尼亚州技术学院 |
双链dna和杂环低聚物之间复合物的形成
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
US7812149B2
(en)
|
1996-06-06 |
2010-10-12 |
Isis Pharmaceuticals, Inc. |
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
|
US20040266706A1
(en)
*
|
2002-11-05 |
2004-12-30 |
Muthiah Manoharan |
Cross-linked oligomeric compounds and their use in gene modulation
|
US6660255B1
(en)
*
|
1996-08-01 |
2003-12-09 |
California Institute Of Technology |
Inhibition of gene transcription by polyamide DNA-binding ligands
|
US6143877A
(en)
*
|
1997-04-30 |
2000-11-07 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides including pyrazolo[3,4-D]pyrimidine bases, bound in double stranded nucleic acids
|
US6312925B1
(en)
|
1997-05-08 |
2001-11-06 |
Epoch Pharmaceuticals, Inc. |
Methods and compositions to facilitate D-loop formation by oligonucleotides
|
US6262252B1
(en)
*
|
1997-05-19 |
2001-07-17 |
Mirus, Inc. |
Single-step method for labeling nucleic acids with mustard or aziridine labeling reagents
|
US6887906B1
(en)
|
1997-07-01 |
2005-05-03 |
Isispharmaceuticals, Inc. |
Compositions and methods for the delivery of oligonucleotides via the alimentary canal
|
US5877309A
(en)
*
|
1997-08-13 |
1999-03-02 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides against JNK
|
US6133246A
(en)
*
|
1997-08-13 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
|
US6809193B2
(en)
|
1997-08-13 |
2004-10-26 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
|
US6518017B1
(en)
*
|
1997-10-02 |
2003-02-11 |
Oasis Biosciences Incorporated |
Combinatorial antisense library
|
US20030165888A1
(en)
*
|
2001-07-18 |
2003-09-04 |
Brown Bob D. |
Oligonucleotide probes and primers comprising universal bases for diagnostic purposes
|
US20060167239A1
(en)
*
|
1997-12-02 |
2006-07-27 |
Slattum Paul M |
Compounds and processes for single-pot attachment of a label to siRNA
|
US6683173B2
(en)
*
|
1998-04-03 |
2004-01-27 |
Epoch Biosciences, Inc. |
Tm leveling methods
|
US6949367B1
(en)
|
1998-04-03 |
2005-09-27 |
Epoch Pharmaceuticals, Inc. |
Modified oligonucleotides for mismatch discrimination
|
US6127121A
(en)
*
|
1998-04-03 |
2000-10-03 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
|
US7045610B2
(en)
*
|
1998-04-03 |
2006-05-16 |
Epoch Biosciences, Inc. |
Modified oligonucleotides for mismatch discrimination
|
US7715989B2
(en)
*
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
US6072046A
(en)
*
|
1998-08-26 |
2000-06-06 |
Epoch Pharmaceuticals, Inc. |
Diaziridinyl-aryl and bis-[di(chloroethyl)amino]-aryl oligonucleotide conjugates and reagents for making the same
|
US6432642B1
(en)
*
|
1999-01-15 |
2002-08-13 |
Pe Corporation (Ny) |
Binary probe and clamp composition and methods for a target hybridization detection
|
US6410231B1
(en)
*
|
1999-02-26 |
2002-06-25 |
Incyte Genomics, Inc. |
SNP detection
|
AU777499B2
(en)
*
|
1999-04-08 |
2004-10-21 |
Gen-Probe Incorporated |
Antisense oligonucleotides comprising universal and/or degenerate bases
|
US6339147B1
(en)
|
1999-07-29 |
2002-01-15 |
Epoch Biosciences, Inc. |
Attachment of oligonucleotides to solid supports through Schiff base type linkages for capture and detection of nucleic acids
|
US6660845B1
(en)
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
US20040081959A9
(en)
*
|
1999-12-08 |
2004-04-29 |
Epoch Biosciences, Inc. |
Fluorescent quenching detection reagents and methods
|
US7205105B2
(en)
*
|
1999-12-08 |
2007-04-17 |
Epoch Biosciences, Inc. |
Real-time linear detection probes: sensitive 5′-minor groove binder-containing probes for PCR analysis
|
US6727356B1
(en)
|
1999-12-08 |
2004-04-27 |
Epoch Pharmaceuticals, Inc. |
Fluorescent quenching detection reagents and methods
|
AU2001243403A1
(en)
*
|
2000-03-01 |
2001-09-12 |
Epoch Biosiences, Inc. |
Modified oligonucleotides for mismatch discrimination
|
EP1944310A3
(en)
|
2000-03-01 |
2008-08-06 |
Epoch Biosciences, Inc. |
Modified oligonucleotides for mismatch discrimination
|
US7078536B2
(en)
*
|
2001-03-14 |
2006-07-18 |
Genesoft Pharmaceuticals, Inc. |
Charged compounds comprising a nucleic acid binding moiety and uses therefor
|
JP2003529609A
(ja)
|
2000-03-16 |
2003-10-07 |
ジーンソフト インコーポレイティッド |
核酸結合部分を含む荷電した化合物およびその利用法
|
AU2001265121A1
(en)
*
|
2000-05-30 |
2001-12-11 |
Applera Corporation |
Methods for detecting target nucleic acids using coupled ligation and amplification
|
US6887664B2
(en)
|
2000-06-06 |
2005-05-03 |
Applera Corporation |
Asynchronous primed PCR
|
US7238795B2
(en)
*
|
2000-08-03 |
2007-07-03 |
Roche Molecular Systems, Inc. |
Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
|
US6358679B1
(en)
*
|
2000-08-24 |
2002-03-19 |
Pe Corporation (Ny) |
Methods for external controls for nucleic acid amplification
|
EP1366057B1
(en)
*
|
2001-03-08 |
2005-12-14 |
Applera Corporation |
Method for deprotecting oligonucleotides
|
US6774082B2
(en)
*
|
2001-05-11 |
2004-08-10 |
Ibc Advanced Technologies, Inc. |
Compositions for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences
|
US20020177157A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Yuling Luo |
Pairs of nucleic acid probes with interactive signaling moieties and nucleic acid probes with enhanced hybridization efficiency and specificity
|
CA2450628A1
(en)
|
2001-06-13 |
2002-12-19 |
Genesoft Pharmaceuticals, Inc. |
Benzothiophene compounds having antiinfective activity
|
US8569516B2
(en)
|
2001-09-07 |
2013-10-29 |
Elitech Holding B.V. |
Compounds and methods for fluorescent labeling
|
US6972339B2
(en)
*
|
2001-09-07 |
2005-12-06 |
Epoch Biosciences, Inc. |
Compounds and methods for fluorescent labeling
|
US6744502B2
(en)
*
|
2001-09-28 |
2004-06-01 |
Pe Corporation (Ny) |
Shaped illumination geometry and intensity using a diffractive optical element
|
US6818420B2
(en)
*
|
2002-02-27 |
2004-11-16 |
Biosource International, Inc. |
Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
|
WO2003078450A2
(en)
*
|
2002-03-11 |
2003-09-25 |
Epoch Biosciences, Inc. |
Negatively charged minor groove binders
|
US7498349B2
(en)
|
2002-08-02 |
2009-03-03 |
Genesoft Pharmaceuticals, Inc. |
Biaryl compounds having anti-infective activity
|
US7153658B2
(en)
*
|
2002-09-19 |
2006-12-26 |
Applera Corporation |
Methods and compositions for detecting targets
|
JP4694201B2
(ja)
*
|
2002-09-20 |
2011-06-08 |
インテグレイテッド ディーエヌエイ テクノロジーズ インコーポレイテッド |
アントラキノン消光色素、それらの製造方法及び使用
|
US20040235005A1
(en)
*
|
2002-10-23 |
2004-11-25 |
Ernest Friedlander |
Methods and composition for detecting targets
|
CA2503119A1
(en)
*
|
2002-10-25 |
2004-05-13 |
Genesoft Pharmaceuticals, Inc. |
Anti-infective biaryl compounds
|
AU2003290598A1
(en)
|
2002-11-05 |
2004-06-03 |
Isis Pharmaceuticals, Inc. |
Modified oligonucleotides for use in rna interference
|
AU2003287270A1
(en)
*
|
2002-11-14 |
2004-06-03 |
The Scripps Research Institute |
PURIFIED COMPOUNDS THAT INHIBIT INTRACELLULAR Alpha4/PAXILLIN BINDING
|
AU2003295692A1
(en)
*
|
2002-11-15 |
2004-06-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for analysis of regulatory sequences
|
WO2004052304A2
(en)
|
2002-12-10 |
2004-06-24 |
Oscient Pharmaceuticals Corporation |
Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
|
WO2005001129A2
(en)
*
|
2003-06-06 |
2005-01-06 |
Applera Corporation |
Mobility cassettes
|
US7348146B2
(en)
*
|
2003-10-02 |
2008-03-25 |
Epoch Biosciences, Inc. |
Single nucleotide polymorphism analysis of highly polymorphic target sequences
|
PT1687609E
(pt)
*
|
2003-10-28 |
2015-03-02 |
Epoch Biosciences Inc |
Sondas fluorescentes para a detecção de adn por hibridação com uma maior sensibilidade e menor ruído de fundo
|
US7439341B2
(en)
|
2003-11-14 |
2008-10-21 |
Integrated Dna Technologies, Inc. |
Fluorescence quenching azo dyes, their methods of preparation and use
|
JP2007534308A
(ja)
*
|
2003-11-19 |
2007-11-29 |
アレロジック・バイオサイエンシズ・コーポレーション |
複数のフルオロフォアで標識したオリゴヌクレオチド
|
US8569474B2
(en)
|
2004-03-09 |
2013-10-29 |
Isis Pharmaceuticals, Inc. |
Double stranded constructs comprising one or more short strands hybridized to a longer strand
|
GB0406015D0
(en)
*
|
2004-03-17 |
2004-04-21 |
Dynal Biotech Asa |
Improvements in magnetic polymer particles
|
US7445898B2
(en)
*
|
2004-04-01 |
2008-11-04 |
Bio-Rad Laboratories, Inc. |
Quantitative amplification with a labeled probe and 3′ to 5′ exonuclease activity
|
WO2005103249A1
(ja)
|
2004-04-26 |
2005-11-03 |
Wako Pure Chemical Industries, Ltd. |
結核菌検出用プライマー及びプローブ、並びにこれを用いたヒト型結核菌の検出方法
|
EP2471924A1
(en)
|
2004-05-28 |
2012-07-04 |
Asuragen, INC. |
Methods and compositions involving microRNA
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
US20070054276A1
(en)
*
|
2004-08-12 |
2007-03-08 |
Sampson Jeffrey R |
Polynucleotide analysis and methods of using nanopores
|
ATE508206T1
(de)
|
2004-08-13 |
2011-05-15 |
Epoch Biosciences Inc |
Amplifikationsverfahren
|
US7884086B2
(en)
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
JP2008513028A
(ja)
|
2004-09-21 |
2008-05-01 |
アプレラ コーポレイション |
マイクロRNA(miRNA)の二色リアルタイム/エンドポイント定量化
|
US20060078894A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Winkler Matthew M |
Methods and compositions for analyzing nucleic acids
|
EP2302055B1
(en)
|
2004-11-12 |
2014-08-27 |
Asuragen, Inc. |
Methods and compositions involving miRNA and miRNA inhibitor molecules
|
WO2006076650A2
(en)
*
|
2005-01-12 |
2006-07-20 |
Applera Corporation |
Compositions, methods, and kits for selective amplification of nucleic acids
|
DE602005018840D1
(de)
|
2005-04-14 |
2010-02-25 |
Applied Biosystems Llc |
3'-modifizierte oligonukleotide mit pseudoisocytosin-nukleobasenderivaten sowie deren anwendungen als primer oder sonden
|
ES2357902T3
(es)
|
2005-05-13 |
2011-05-03 |
Wako Pure Chemical Industries, Ltd. |
Cebadores, sondas, procedimientos y usos de los mismos para la detección de mycobacteriium kansasii.
|
JP2008545659A
(ja)
|
2005-05-20 |
2008-12-18 |
インテグレイテッド ディーエヌエイ テクノロジーズ インコーポレイテッド |
オリゴヌクレオチドを標識する化合物及び方法
|
US20070048758A1
(en)
*
|
2005-06-09 |
2007-03-01 |
Epoch Biosciences, Inc. |
Improved primer-based amplification methods
|
US20070087360A1
(en)
*
|
2005-06-20 |
2007-04-19 |
Boyd Victoria L |
Methods and compositions for detecting nucleotides
|
CA2624634A1
(en)
|
2005-10-03 |
2007-04-12 |
Applera Corporation |
Compositions, methods, and kits for amplifying nucleic acids
|
ATE553220T1
(de)
|
2006-03-13 |
2012-04-15 |
Wako Pure Chem Ind Ltd |
Verfahren zur erkennung eines mutierten gens
|
US20080166712A1
(en)
*
|
2006-04-10 |
2008-07-10 |
Ryusuke Murayama |
Gene detection method
|
CN101432426B
(zh)
|
2006-05-02 |
2012-09-19 |
和光纯药工业株式会社 |
胞内分枝杆菌检测用引物和探针、以及使用该引物和探针的胞内分枝杆菌的检测方法
|
EP2029726A4
(en)
*
|
2006-06-09 |
2010-07-28 |
Univ Miami |
EVALUATION OF CELL COMPOSITION AND FRACTIONAL VIABILITY AND USES THEREOF
|
WO2008002920A2
(en)
*
|
2006-06-26 |
2008-01-03 |
Epoch Biosciences, Inc. |
Methods for generating target nucleic acid sequences
|
EP2484781B1
(en)
|
2006-08-01 |
2017-08-23 |
Applied Biosystems, LLC |
Detection of analytes and nucleic acids
|
AU2007281082A1
(en)
|
2006-08-04 |
2008-02-07 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the modulation of JNK proteins
|
GB0619325D0
(en)
*
|
2006-09-30 |
2006-11-08 |
Univ Strathclyde |
New compounds
|
US20080131878A1
(en)
*
|
2006-12-05 |
2008-06-05 |
Asuragen, Inc. |
Compositions and Methods for the Detection of Small RNA
|
US7902345B2
(en)
*
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
US8133701B2
(en)
*
|
2006-12-05 |
2012-03-13 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
AU2007333106A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
miR-20 regulated genes and pathways as targets for therapeutic intervention
|
CN104531684A
(zh)
|
2006-12-18 |
2015-04-22 |
和光纯药工业株式会社 |
鸟分枝杆菌检测用引物和探针、以及使用它们检测鸟分枝杆菌的方法
|
US9938641B2
(en)
*
|
2006-12-18 |
2018-04-10 |
Fluidigm Corporation |
Selection of aptamers based on geometry
|
AU2008251381B2
(en)
|
2007-05-11 |
2014-10-30 |
The Johns Hopkins University |
Biomarkers for melanoma
|
US8143006B2
(en)
*
|
2007-08-03 |
2012-03-27 |
Igor Kutyavin |
Accelerated cascade amplification (ACA) of nucleic acids comprising strand and sequence specific DNA nicking
|
US8071338B2
(en)
*
|
2007-08-08 |
2011-12-06 |
Roche Molecular Systems, Inc. |
Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5′-3′ nuclease activity
|
ATE549419T1
(de)
|
2007-08-29 |
2012-03-15 |
Sequenom Inc |
Verfahren und zusammensetzungen für die universelle grössenspezifische polymerasekettenreaktion
|
EP2198050A1
(en)
|
2007-09-14 |
2010-06-23 |
Asuragen, INC. |
Micrornas differentially expressed in cervical cancer and uses thereof
|
WO2009045536A2
(en)
*
|
2007-10-05 |
2009-04-09 |
The University Of North Carolina At Chapel Hill |
Receptor targeted oligonucleotides
|
WO2009052386A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Asuragen, Inc. |
Micrornas differentially expressed in lung diseases and uses thereof
|
WO2009070805A2
(en)
|
2007-12-01 |
2009-06-04 |
Asuragen, Inc. |
Mir-124 regulated genes and pathways as targets for therapeutic intervention
|
EP2546344A3
(en)
|
2008-02-08 |
2013-04-03 |
Wako Pure Chemical Industries, Ltd. |
Primer and probe for detecting chlamydophilia caviae, as well as chlamydophilia caviae detection method using the same
|
EP2268608A4
(en)
|
2008-04-01 |
2012-01-11 |
Biosearch Technologies Inc |
DARK NUCLEIC ACID STABILIZED FLUOROPHORE DEACTIVATOR PROBES
|
WO2009126726A1
(en)
*
|
2008-04-08 |
2009-10-15 |
Asuragen, Inc |
Methods and compositions for diagnosing and modulating human papillomavirus (hpv)
|
WO2009126933A2
(en)
|
2008-04-11 |
2009-10-15 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
US8258111B2
(en)
|
2008-05-08 |
2012-09-04 |
The Johns Hopkins University |
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
|
ES2650066T3
(es)
|
2008-05-28 |
2018-01-16 |
Wako Pure Chemical Industries, Ltd. |
Cebador y sonda para la detección de Mycobacterium intracellulare, y método para la detección de Mycobacterium intracellulare empleando el cebador o la sonda
|
US8097412B2
(en)
*
|
2008-07-12 |
2012-01-17 |
Biodiagnostics, Inc. |
DNA-based test for detection of annual and intermediate ryegrass
|
WO2010030716A1
(en)
*
|
2008-09-10 |
2010-03-18 |
Igor Kutyavin |
Detection of nucleic acids by oligonucleotide probes cleaved in presence of endonuclease v
|
CN104328109A
(zh)
*
|
2008-09-22 |
2015-02-04 |
霍夫曼-拉罗奇有限公司 |
微阵列底物上的生物材料的选择性处理
|
WO2010039548A2
(en)
|
2008-09-23 |
2010-04-08 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
EP3238738B1
(en)
|
2008-11-10 |
2020-09-23 |
Arbutus Biopharma Corporation |
Novel lipids and compositions for the delivery of therapeutics
|
WO2010077324A2
(en)
|
2008-12-17 |
2010-07-08 |
Life Technologies Corporation |
Methods, compositions, and kits for detecting allelic variants
|
EP2669290A1
(en)
|
2009-03-02 |
2013-12-04 |
Alnylam Pharmaceuticals Inc. |
Nucleic Acid Chemical Modifications
|
CA2755615A1
(en)
*
|
2009-03-18 |
2010-09-23 |
Sequenom, Inc. |
Use of thermostable endonucleases for generating reporter molecules
|
EP3249053A1
(en)
|
2009-03-27 |
2017-11-29 |
Life Technologies Corporation |
Methods, compositions, and kits for detecting allelic variants
|
SI3431076T1
(sl)
|
2009-06-10 |
2022-04-29 |
Arbutus Biopharma Corporation |
Izboljšana lipidna formulacija
|
DK2462230T3
(en)
|
2009-08-03 |
2015-10-19 |
Recombinetics Inc |
METHODS AND COMPOSITIONS FOR TARGETED RE-MODIFICATION
|
EP2483425B1
(en)
|
2009-09-28 |
2016-08-24 |
Igor Kutyavin |
Methods and compositions for detection of nucleic acids based on stabilized oligonucleotide probe complexes
|
WO2011046972A2
(en)
*
|
2009-10-12 |
2011-04-21 |
Life Technologies Corporation |
Compositions and methods for suppressing primer interactions
|
CN103025872A
(zh)
*
|
2009-11-25 |
2013-04-03 |
艾泰控股有限公司 |
小沟结合剂(MGB)-寡核苷酸miRNA拮抗剂
|
EP3296398A1
(en)
|
2009-12-07 |
2018-03-21 |
Arbutus Biopharma Corporation |
Compositions for nucleic acid delivery
|
AU2010330814B2
(en)
|
2009-12-18 |
2017-01-12 |
Acuitas Therapeutics Inc. |
Methods and compositions for delivery of nucleic acids
|
WO2011087707A1
(en)
|
2009-12-22 |
2011-07-21 |
Elitech Holding B.V. |
Hypertheromostable endonuclease iv substrate probe
|
WO2011094580A2
(en)
|
2010-01-28 |
2011-08-04 |
Alnylam Pharmaceuticals, Inc. |
Chelated copper for use in the preparation of conjugated oligonucleotides
|
WO2011100131A2
(en)
|
2010-01-28 |
2011-08-18 |
Alnylam Pharmacuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
EP2557156B1
(en)
|
2010-03-23 |
2015-02-11 |
Wako Pure Chemical Industries, Ltd. |
Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US8916345B2
(en)
*
|
2010-03-26 |
2014-12-23 |
Integrated Dna Technologies, Inc. |
Methods for enhancing nucleic acid hybridization
|
EP2552947A4
(en)
|
2010-03-26 |
2013-11-13 |
Dartmouth College |
VISTA REGULATORY T CELL MEDIATOR PROTEIN, VISTA BINDING ACTIVE SUBSTANCES AND USE THEREOF
|
US9506057B2
(en)
|
2010-03-26 |
2016-11-29 |
Integrated Dna Technologies, Inc. |
Modifications for antisense compounds
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
WO2011123621A2
(en)
|
2010-04-01 |
2011-10-06 |
Alnylam Pharmaceuticals Inc. |
2' and 5' modified monomers and oligonucleotides
|
AU2011243039B2
(en)
|
2010-04-16 |
2015-01-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Real time PCR assay for detection of bacterial respiratory pathogens
|
WO2011133876A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising acyclic and abasic nucleosides and analogs
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
WO2011133868A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
Conformationally restricted dinucleotide monomers and oligonucleotides
|
GB201007868D0
(en)
|
2010-05-11 |
2010-06-23 |
Enigma Diagnostics Ltd |
Sequence detection assay
|
WO2011143611A2
(en)
|
2010-05-14 |
2011-11-17 |
Life Technologies Corporation |
Karyotyping assay
|
US8658776B2
(en)
|
2010-05-28 |
2014-02-25 |
Life Technologies Corporation |
Synthesis of 2′,3′-dideoxynucleosides for automated DNA synthesis and pyrophosphorolysis activated polymerization
|
EP2576599B1
(en)
|
2010-06-02 |
2015-03-18 |
Merck Patent GmbH |
A genetically modified bacterium of the species listeria monocytogenes
|
WO2011163121A1
(en)
|
2010-06-21 |
2011-12-29 |
Alnylam Pharmaceuticals, Inc. |
Multifunctional copolymers for nucleic acid delivery
|
US20130189268A1
(en)
|
2010-06-22 |
2013-07-25 |
Precision Biologics, Inc. |
Colon and pancreas cancer specific antigens and antibodies
|
US20130202652A1
(en)
|
2010-07-30 |
2013-08-08 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
US20130323269A1
(en)
|
2010-07-30 |
2013-12-05 |
Muthiah Manoharan |
Methods and compositions for delivery of active agents
|
CA2809457C
(en)
|
2010-09-07 |
2019-07-30 |
Integrated Dna Technologies, Inc. |
Modifications for antisense compounds
|
CA2812556C
(en)
|
2010-09-23 |
2023-02-14 |
Xue-Ping Wang |
Colon and pancreas cancer peptidomimetics
|
ES2847891T3
(es)
|
2010-11-23 |
2021-08-04 |
Vitaeris Inc |
Anticuerpos anti-IL-6 para el tratamiento de la mucositis oral
|
CA2824526C
(en)
|
2011-01-11 |
2020-07-07 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
WO2012125220A2
(en)
|
2011-01-14 |
2012-09-20 |
Life Technologies Corporation |
Methods for isolation, identification, and quantification of mirnas
|
ES2728743T3
(es)
|
2011-01-17 |
2019-10-28 |
Life Technologies Corp |
Flujo de trabajo para la detección de ligandos utilizando ácidos nucleicos
|
US8969003B2
(en)
|
2011-03-23 |
2015-03-03 |
Elitech Holding B.V. |
Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use
|
EP2689031B1
(en)
|
2011-03-23 |
2016-10-19 |
ELITechGroup B.V. |
Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use
|
WO2012142003A2
(en)
|
2011-04-15 |
2012-10-18 |
Life Technologies Corporation |
Chemical ligation
|
ES2537189T3
(es)
|
2011-05-24 |
2015-06-03 |
Elitech Holding B.V. |
Detección de estafilococos áureos resistentes a la meticilina
|
AU2012260601B2
(en)
|
2011-05-25 |
2018-02-01 |
Innate Pharma, S.A. |
Anti-KIR antibodies for the treatment of inflammatory disorders
|
US9567628B2
(en)
|
2011-06-08 |
2017-02-14 |
Life Technologies Corporation |
Polymerization of nucleic acids using proteins having low isoelectric points
|
ES2692894T3
(es)
|
2011-06-08 |
2018-12-05 |
Life Technologies Corporation |
Diseño y desarrollo de nuevos detergentes para su uso en sistemas de PCR
|
WO2012178187A1
(en)
|
2011-06-23 |
2012-12-27 |
Paul Yager |
Reagent patterning in capillarity-based analyzers and associated systems and methods
|
WO2013016321A1
(en)
|
2011-07-26 |
2013-01-31 |
Elitech Holding B.V. |
Minor groove binder phosphoramidites and methods of use
|
WO2013040251A2
(en)
|
2011-09-13 |
2013-03-21 |
Asurgen, Inc. |
Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
|
US9701623B2
(en)
|
2011-09-27 |
2017-07-11 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted pegylated lipids
|
GB201119903D0
(en)
*
|
2011-11-17 |
2011-12-28 |
Univ Vilnius |
Nucleic acid production and sequence analysis
|
US8981318B1
(en)
|
2011-12-30 |
2015-03-17 |
Gene Capture, Inc. |
Multi-dimensional scanner for nano-second time scale signal detection
|
CN107674071B
(zh)
|
2012-05-11 |
2021-12-31 |
同步制药公司 |
作为隐花色素调节剂的含有咔唑的磺酰胺类
|
US9394574B2
(en)
|
2012-06-12 |
2016-07-19 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods for detecting Legionella nucleic acids in a sample
|
CN110343673B
(zh)
|
2012-06-14 |
2024-04-05 |
生命技术公司 |
用于聚合酶链式反应(pcr)的新型组合物、方法和试剂盒
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
AU2013277051B2
(en)
|
2012-06-22 |
2018-06-07 |
King's College London |
Novel VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
AU2013312211B2
(en)
|
2012-09-07 |
2018-03-29 |
King's College London |
VISTA modulators for diagnosis and treatment of cancer
|
EP2904120B1
(en)
|
2012-10-04 |
2018-01-10 |
The Board of Trustees of The Leland Stanford Junior University |
Methods and reagents for detection, quantitation, and serotyping of dengue viruses
|
CN111793621A
(zh)
|
2012-11-02 |
2020-10-20 |
生命技术公司 |
用于增强pcr特异性的新颖组合物、方法和试剂盒
|
CA2896723C
(en)
|
2012-12-28 |
2024-02-13 |
Precision Biologics, Inc. |
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
|
CN105050720A
(zh)
|
2013-01-22 |
2015-11-11 |
华盛顿大学商业化中心 |
顺序递送流体体积和相关的设备、系统和方法
|
CN105339505B
(zh)
|
2013-03-12 |
2021-08-10 |
生命技术公司 |
基于通用报告体的基因分型方法和材料
|
WO2014164874A2
(en)
|
2013-03-13 |
2014-10-09 |
Becton, Dickinson And Company |
Methods and compositions for modulation of amplification efficiency
|
EP2971086A1
(en)
|
2013-03-14 |
2016-01-20 |
ELITechGroup B.V. |
Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use
|
JP2016515380A
(ja)
|
2013-03-15 |
2016-05-30 |
ライフ テクノロジーズ コーポレーション |
肺癌の分類及び実施可能性インデックス
|
CA2918194C
(en)
|
2013-03-27 |
2022-12-06 |
The General Hospital Corporation |
Methods and agents for treating alzheimer's disease
|
WO2014165710A2
(en)
|
2013-04-05 |
2014-10-09 |
Life Technologies Corporation |
Gene fusions
|
ES2654631T3
(es)
|
2013-05-13 |
2018-02-14 |
Elitechgroup B.V. |
PCR digital en gotas con sondas cortas de ranura menor
|
CN105722996A
(zh)
|
2013-09-13 |
2016-06-29 |
生命科技公司 |
癌症的分类和可行性指数
|
WO2015061475A2
(en)
|
2013-10-22 |
2015-04-30 |
THE GOVERNMENT OF THE USA as represented by THE SECRETARY OF THE DEPARTMENT OF HEATLH AND HUMAN SERV |
Compositions and methods for detection and discrimination of influenza viruses
|
EP3063129B1
(en)
|
2013-10-25 |
2019-04-17 |
Life Technologies Corporation |
Novel compounds for use in pcr systems and applications thereof
|
JP6466437B2
(ja)
|
2013-10-30 |
2019-02-06 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
微生物を複雑な試料から単離する方法
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
WO2015097536A2
(en)
|
2013-12-24 |
2015-07-02 |
Janssen Pharmaceutical Nv |
Anti-vista antibodies and fragments
|
US20170058366A1
(en)
|
2014-02-21 |
2017-03-02 |
The United States of America, as represented by th e Secretary, Dept. of Health and Human Services |
Hiv-2 nucleic acids and methods of detection
|
WO2015149034A2
(en)
|
2014-03-27 |
2015-10-01 |
Life Technologies Corporation |
Gene fusions and gene variants associated with cancer
|
TWI690521B
(zh)
|
2014-04-07 |
2020-04-11 |
美商同步製藥公司 |
作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
|
US20170044631A1
(en)
|
2014-04-14 |
2017-02-16 |
The Unite States of America, as represented by the Secretary, Dept. of Health and Human Services |
Methods for rapid detection and identification of viral nucleic acids
|
AU2015274504B2
(en)
|
2014-06-11 |
2021-02-04 |
Kathy A. Green |
Use of VISTA agonists and antagonists to suppress or enhance humoral immunity
|
KR20170016915A
(ko)
|
2014-06-11 |
2017-02-14 |
마이크로닉스 인코포레이티드. |
핵산의 분석을 위한 통합 검정 대조군을 갖는 마이크로 유체 공학적 카트리지 및 장치
|
US9212388B1
(en)
|
2014-06-30 |
2015-12-15 |
Life Technologies Corporation |
Direct quantitative PCR absent minor groove binders
|
WO2016061111A1
(en)
|
2014-10-13 |
2016-04-21 |
Life Technologies Corporation |
Methods, kits & compositions for determining gene copy numbers
|
AU2015357463B2
(en)
|
2014-12-05 |
2021-10-07 |
Immunext, Inc. |
Identification of VSIG8 as the putative vista receptor and its use thereof to produce vista/VSIG8 modulators
|
US10266903B2
(en)
|
2014-12-12 |
2019-04-23 |
Elitechgroup, Inc. |
Methods and compositions for detecting antibiotic resistant bacteria
|
EP3230468B1
(en)
|
2014-12-12 |
2020-09-16 |
ELITechGroup, Inc. |
Methods and kits for detecting antibiotic resistant bacteria
|
AU2015364508A1
(en)
|
2014-12-18 |
2017-07-06 |
Alnylam Pharmaceuticals, Inc. |
ReversirTM compounds
|
BR112017027870A2
(pt)
|
2015-06-24 |
2018-08-28 |
Janssen Pharmaceutica Nv |
anticorpos e fragmentos anti-vista
|
WO2017015109A1
(en)
|
2015-07-17 |
2017-01-26 |
Alnylam Pharmaceuticals, Inc. |
Multi-targeted single entity conjugates
|
US10899836B2
(en)
|
2016-02-12 |
2021-01-26 |
Janssen Pharmaceutica Nv |
Method of identifying anti-VISTA antibodies
|
CA3020848A1
(en)
|
2016-04-15 |
2017-10-19 |
Janssen Pharmaceuticals, Inc. |
Anti-human vista antibodies and use thereof
|
WO2017200790A1
(en)
|
2016-05-20 |
2017-11-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Real-time reverse transcriptase-polymerase chain reaction assay with modified probe for the diagnosis of rabies viruses and other lyssaviruses
|
WO2017218938A1
(en)
|
2016-06-16 |
2017-12-21 |
Life Technologies Corporation |
Novel compositions, methods and kits for microorganism detection
|
WO2018005284A1
(en)
|
2016-06-27 |
2018-01-04 |
The United State Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for influenza a virus subtyping
|
US11613777B2
(en)
|
2016-08-26 |
2023-03-28 |
Life Technologies Corporation |
Nucleic acid extraction and amplification controls and methods of use thereof
|
WO2018047148A1
(en)
|
2016-09-12 |
2018-03-15 |
Novartis Ag |
Compounds for the inhibition of mirna
|
WO2018162516A1
(en)
|
2017-03-08 |
2018-09-13 |
Etablissement Francais Du Sang |
Rhd gene allele associated with a weak d phenotype and its uses
|
WO2018162986A2
(en)
|
2017-03-09 |
2018-09-13 |
Elitechgroup B.V. |
Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes
|
EP3668884B1
(en)
|
2017-08-17 |
2022-03-09 |
ELITechGroup Inc. |
Duplex stabilizing fluorescence quenchers for nucleic acid probes
|
JP2021502825A
(ja)
|
2017-11-13 |
2021-02-04 |
ライフ テクノロジーズ コーポレイション |
尿路微生物検出のための組成物、方法、およびキット
|
US10689629B1
(en)
|
2017-12-06 |
2020-06-23 |
Cepheid |
Inhibition of nucleic acid polymerases by endonuclease V-cleavable circular oligonucleotide ligands
|
US10724017B1
(en)
|
2017-12-06 |
2020-07-28 |
Cepheid |
Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands
|
US10724083B1
(en)
|
2017-12-06 |
2020-07-28 |
Cepheid |
Inhibition of nucleic acid polymerases by endonuclease V-cleavable oligonucleotide ligands
|
CA3098623A1
(en)
|
2018-05-07 |
2019-11-14 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|
EP3802526A1
(en)
|
2018-05-29 |
2021-04-14 |
ELITechGroup, Inc. |
Carborhodamine compounds and methods of preparation thereof
|
WO2020037290A1
(en)
|
2018-08-16 |
2020-02-20 |
Life Technologies Corporation |
Reagents, mixtures, kits and methods for amplification of nucleic acids
|
EP3856907A1
(en)
|
2018-09-28 |
2021-08-04 |
Alnylam Pharmaceuticals, Inc. |
Transthyretin (ttr) irna compositions and methods of use thereof for treating or preventing ttr-associated ocular diseases
|
JP7432610B2
(ja)
|
2018-10-01 |
2024-02-16 |
ジェン-プローブ・インコーポレーテッド |
水痘帯状疱疹ウイルスを増幅または検出するための組成物および方法
|
US20220211743A1
(en)
|
2019-05-17 |
2022-07-07 |
Alnylam Pharmaceuticals, Inc. |
Oral delivery of oligonucleotides
|
WO2021086753A1
(en)
*
|
2019-10-28 |
2021-05-06 |
Geron Corporation |
Amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane salts and methods of making the same
|
EP4055165A1
(en)
|
2019-11-06 |
2022-09-14 |
Alnylam Pharmaceuticals, Inc. |
Transthyretin (ttr) irna compositions and methods of use thereof for treating or preventing ttr-associated ocular diseases
|
CN114945669A
(zh)
|
2019-11-06 |
2022-08-26 |
阿尔尼拉姆医药品有限公司 |
肝外递送
|
BR112022016493A2
(pt)
|
2020-02-18 |
2022-10-25 |
Life Technologies Corp |
Composições, kits e métodos para detecção de sequências virais
|
EP3929310A1
(en)
|
2020-06-26 |
2021-12-29 |
FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. |
Methods and means for corona virus nucleic acid detection
|
DE202021100985U1
(de)
|
2020-06-26 |
2021-06-18 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein |
Ein diagnostisches Assay-Kit und Mittel zum Nachweis von Coronavirus-Nukleinsäure
|
US20230257745A1
(en)
|
2020-07-10 |
2023-08-17 |
Alnylam Pharmaceuticals, Inc. |
Circular siRNAs
|
CA3186955A1
(en)
|
2020-07-23 |
2022-01-27 |
Scott Benson |
Energy transfer dye conjugates for use in biological assays
|
EP4185858A2
(en)
|
2020-07-23 |
2023-05-31 |
Life Technologies Corporation |
Compositions, systems and methods for biological analysis using dyes
|
WO2022147214A2
(en)
|
2020-12-31 |
2022-07-07 |
Alnylam Pharmaceuticals, Inc. |
Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
|
EP4271695A2
(en)
|
2020-12-31 |
2023-11-08 |
Alnylam Pharmaceuticals, Inc. |
2'-modified nucleoside based oligonucleotide prodrugs
|
EP4278002A2
(en)
|
2021-01-18 |
2023-11-22 |
Life Technologies Corporation |
Compositions, kits and methods for direct amplification from crude biological samples
|
WO2022159874A1
(en)
|
2021-01-25 |
2022-07-28 |
Life Technologies Corporation |
Compositions, kits and methods for detection of viral variant sequences
|
WO2022203748A1
(en)
|
2021-03-23 |
2022-09-29 |
Life Technologies Corporation |
Compositions, kits, and methods for variant-resistant detection of target viral sequences
|
EP4074839A1
(en)
|
2021-04-16 |
2022-10-19 |
Biotype GmbH |
Optimized oligonucleotide tx probe for a multiplexing analysis of nucleic acids and a multiplexing method
|
WO2023283403A2
(en)
|
2021-07-09 |
2023-01-12 |
Alnylam Pharmaceuticals, Inc. |
Bis-rnai compounds for cns delivery
|
WO2023004400A1
(en)
|
2021-07-21 |
2023-01-26 |
Life Technologies Corporation |
Dibenzoxanthene quenchers, uses, and methods of preparation
|
WO2023003922A1
(en)
|
2021-07-21 |
2023-01-26 |
Alnylam Pharmaceuticals, Inc. |
Metabolic disorder-associated target gene irna compositions and methods of use thereof
|
WO2023014729A1
(en)
|
2021-08-02 |
2023-02-09 |
Life Technologies Corporation |
Compositions, kits, and methods for detection of nucleic acid sequence loads
|
WO2023064530A1
(en)
|
2021-10-15 |
2023-04-20 |
Alnylam Pharmaceuticals, Inc. |
Extra-hepatic delivery irna compositions and methods of use thereof
|
WO2023069604A1
(en)
|
2021-10-20 |
2023-04-27 |
Life Technologies Corporation |
Compositions, kits, and methods for quantification of nucleic acid sequences using an internal quantitative standard
|
WO2023220744A2
(en)
|
2022-05-13 |
2023-11-16 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
CN114672482B
(zh)
*
|
2022-05-31 |
2022-08-30 |
上海百力格生物技术有限公司 |
核酸探针制备方法
|
WO2024006927A1
(en)
|
2022-06-29 |
2024-01-04 |
Life Technologies Corporation |
Compositions, kits, and methods for detecting nucleic acids using intra-channel multiplexing
|
WO2024006924A1
(en)
|
2022-06-29 |
2024-01-04 |
Life Technologies Corporation |
Systems and methods for analyte detection from multiplexed assays
|
WO2024006999A2
(en)
|
2022-06-30 |
2024-01-04 |
Alnylam Pharmaceuticals, Inc. |
Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
|
WO2024054925A1
(en)
|
2022-09-09 |
2024-03-14 |
Life Technologies Corporation |
Compositions, kits and methods for detection of viral variant sequences
|
WO2024073732A1
(en)
|
2022-09-30 |
2024-04-04 |
Alnylam Pharmaceuticals, Inc. |
Modified double-stranded rna agents
|
EP4350002A1
(en)
|
2022-10-07 |
2024-04-10 |
Biotype GmbH |
Nachweis von molekularen analyten auf der grundlage massgeschneiderter sondenkonkurrenz
|